Search research articles
Contact Us
Filters
Showing results (251-260 of 337) with videos related to
Page
of 34
Sort By:
Contact Dermatitis
|
March 5, 2025
The Prevalence and Severity of Hand Eczema Among Adults in Tasiilaq, East Greenland
Morten Bahrt Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
JAMA Dermatology
|
March 29, 2018
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR
Kayleigh J Mason, Jonathan N W N Barker, Catherine H Smith, et al.
Acta Dermato-Venereologica
|
September 6, 2022
Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study
Ireny Y K Iskandar, Teng-Chou Chen, Li-Chia Chen, et al.
Journal of the American Academy of Dermatology
|
March 12, 2005
Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors
Tracy J Lovatt, John T Lear, Jean Bastrilles, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Predicting Proteolysis in Complex Proteomes Using Deep Learning
Matiss Ozols, Alexander Eckersley, Christopher I Platt, et al.
International Journal of Circumpolar Health
|
October 3, 2024
Skin diseases among adults in Tasiilaq, East Greenland
Morten B Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
The Journal of Investigative Dermatology
|
July 22, 2018
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis
Amy C Foulkes, David S Watson, Daniel F Carr, et al.
Journal of the American Academy of Dermatology
|
June 20, 2015
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Kim Papp, Kristian Reich, Craig L Leonardi, et al.
Journal of Drugs in Dermatology : JDD
|
August 2, 2024
Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas
Alice B Gottlieb, April Armstrong, Andrew Blauvelt, et al.
The Journal of Investigative Dermatology
|
November 17, 2015
Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy
Christopher E M Griffiths, Michael R Barnes, A David Burden, et al.
Page
of 34
Search research articles
Search
Showing results (251-260 of 337) with videos related to
Sort By:
Page
of 34
Contact Dermatitis
|
March 5, 2025
The Prevalence and Severity of Hand Eczema Among Adults in Tasiilaq, East Greenland
Morten Bahrt Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
JAMA Dermatology
|
March 29, 2018
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR
Kayleigh J Mason, Jonathan N W N Barker, Catherine H Smith, et al.
Acta Dermato-Venereologica
|
September 6, 2022
Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study
Ireny Y K Iskandar, Teng-Chou Chen, Li-Chia Chen, et al.
Journal of the American Academy of Dermatology
|
March 12, 2005
Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors
Tracy J Lovatt, John T Lear, Jean Bastrilles, et al.
International Journal of Molecular Sciences
|
April 3, 2021
Predicting Proteolysis in Complex Proteomes Using Deep Learning
Matiss Ozols, Alexander Eckersley, Christopher I Platt, et al.
International Journal of Circumpolar Health
|
October 3, 2024
Skin diseases among adults in Tasiilaq, East Greenland
Morten B Haulrig, Anna M Andersson, Julia-Tatjana Maul, et al.
The Journal of Investigative Dermatology
|
July 22, 2018
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis
Amy C Foulkes, David S Watson, Daniel F Carr, et al.
Journal of the American Academy of Dermatology
|
June 20, 2015
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Kim Papp, Kristian Reich, Craig L Leonardi, et al.
Journal of Drugs in Dermatology : JDD
|
August 2, 2024
Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas
Alice B Gottlieb, April Armstrong, Andrew Blauvelt, et al.
The Journal of Investigative Dermatology
|
November 17, 2015
Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy
Christopher E M Griffiths, Michael R Barnes, A David Burden, et al.
Page
of 34